Qingdao Vland Biotech Co Ltd (603739) — Cash Flow Quality Index
Qingdao Vland Biotech Co Ltd (603739) has a Cash Flow Quality Index of 0.69x as of September 2025. Operating cash flow of CN¥24.29 Million is below net income of CN¥35.06 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Qingdao Vland Biotech Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Qingdao Vland Biotech Co Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for Qingdao Vland Biotech Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Qingdao Vland Biotech Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Qingdao Vland Biotech Co Ltd (2014–2024)
Year-by-year earnings quality comparison for Qingdao Vland Biotech Co Ltd. For live market cap and the full company financial profile, see Qingdao Vland Biotech Co Ltd stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.12x | CN¥195.41 Million | CN¥92.17 Million | ▲ +42.0% |
| 2023 | 1.49x | CN¥153.59 Million | CN¥102.86 Million | ▲ +33.8% |
| 2022 | 1.12x | CN¥95.31 Million | CN¥85.41 Million | ▲ +87.1% |
| 2021 | 0.60x | CN¥89.51 Million | CN¥150.10 Million | ▼ -57.8% |
| 2020 | 1.41x | CN¥173.00 Million | CN¥122.30 Million | ▲ +93.6% |
| 2019 | 0.73x | CN¥65.33 Million | CN¥89.39 Million | ▼ -20.8% |
| 2018 | 0.92x | CN¥85.75 Million | CN¥92.94 Million | ▼ -30.0% |
| 2017 | 1.32x | CN¥121.90 Million | CN¥92.53 Million | ▼ -23.7% |
| 2016 | 1.73x | CN¥154.49 Million | CN¥89.49 Million | ▲ +80.5% |
| 2015 | 0.96x | CN¥74.27 Million | CN¥77.67 Million | ▼ -2.6% |
| 2014 | 0.98x | CN¥58.55 Million | CN¥59.65 Million | — |